Rocket Lab Corp·4

May 28, 8:22 PM ET

Clevenger Marvin Bradford 4

Research Summary

AI-generated summary

Updated

Rocket Lab (RKLB) President Marvin Clevenger Sells Shares

What Happened

  • Marvin Bradford Clevenger, President of Rocket Lab USA, Inc., sold a total of 15,549 Rocket Lab (RKLB) shares in multiple open-market transactions on May 26, 2026, generating approximately $2,216,874. The individual tranches were:
    • 411 shares at $139.41 — $57,298
    • 1,222 shares at $140.20 — $171,326
    • 1,519 shares at $141.46 — $214,872
    • 4,524 shares at $142.35 — $644,014
    • 6,055 shares at $143.24 — $867,338
    • 1,818 shares at $144.13 — $262,026
  • These were sales (not purchases). Footnotes indicate the primary reason was a "sell-to-cover" to satisfy tax withholding obligations related to the vesting and settlement of previously granted restricted stock units (RSUs), which is a routine tax-related sale.

Key Details

  • Transaction date: May 26, 2026; Form 4 filed May 28, 2026 (timely — within typical 2-business-day window).
  • Total shares sold: 15,549; total proceeds: ~$2.22 million.
  • Reported price range across all transactions (per footnotes): $138.77 to $144.76; some line items report weighted-average prices for multiple trades within narrower ranges.
  • Notable footnotes: F1 — sale was "sell-to-cover" for tax withholding on RSU vesting; F2–F8 — explain weighted-average pricing and per-tranche price ranges; F3 — references 589 shares acquired under the company ESPP (exempt under Rule 16b-3).
  • Shares owned after the transaction: not reported in the provided excerpt of the Form 4.

Context

  • "Sell-to-cover" sales are common when RSUs vest and are used to pay required taxes; they do not necessarily reflect a change in the insider’s view of the company.
  • This filing documents sales (S). For retail investors, purchases typically carry clearer potential signals of insider confidence; routine tax-withholding sales are common and often neutral.